The application of visceral adiposity index in identifying type 2 diabetes risks based on a prospective cohort in China

Lipids in Health and Disease

Xiao-shu Hu³  Ming Wu³  Jie Yang²  Zhi-rong Guo⁴  Yan Xu¹  Chen Chen² 

[1] Department of Immune Planning, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China;Department of Chronic Diseases Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China;Jiangsu Provincial Center for Disease Control and Prevention, No. 172, Jiangsu Road, Nanjing 210009, China;School of Public Health, Soochow University, Suzhou, Jiangsu 215123, China

关键词: Waist-to-height ratio;    Waist circumference;    Body mass index;    Visceral adiposity index;    Diabetes;   

Others  :  1159987
DOI  :  10.1186/1476-511X-13-108

 received in 2014-03-09, accepted in 2014-07-01,  发布年份 2014

【 摘 要 】

Background

Visceral adiposity index (VAI), a novel sex-specific index for visceral fat measurement, has been proposed recently. We evaluate the efficacy of VAI in identifying diabetes risk in Chinese people, and compare the predictive ability between VAI and other body fatness indices, i.e., waist circumference (WC), body mass index (BMI) and waist- to- height ratio (WHtR).

Methods

Participants (n = 3,461) were recruited from an ongoing cohort study in Jiangsu Province, China. Hazard ratio (HR) and corresponding 95% confidence interval (CI) between diabetes risk and different body fatness indices were evaluated by Cox proportional hazard regression model. Receiver operating characteristic (ROC) curve and area under curve (AUC) were applied to compare the ability of identifying diabetes risk between VAI, WC, WHtR and BMI.

Results

A total number of 160 new diabetic cases occurred during the follow-up, with an incidence of 4.6%. Significant positive associations were observed for VAI with blood pressure, fasting plasma glucose, triglyceride, WC, BMI and WHtR. Moreover, increased VAI was observed to be associated with higher diabetes risk with a positive dose–response trend (p for trend < 0.001). As compared to individuals with the lowest VAI, those who had the highest VAI were at 2.55-fold risk of diabetes (95% CI: 1.58-4.11). The largest AUC was observed for VAI, following by WC, WHtR and BMI.

Conclusions

VAI is positively associated with the risk of diabetes. Compared to other indices for body fatness measurements, VAI is a better and convenience surrogate marker for visceral adipose measurement and could be used in identifying the risk of diabetes in large-scale epidemiologic studies.

【 授权许可】

   
2014 Chen et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Herman WH: Diabetes epidemiology: guiding clinical and public health practice, the Kelly West Award Lecture, 2006. Diabetes Care 2007, 30:1912-1919.
• [2]Harati H, Hadaegh F, Saadat N, Azizi F: Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC Public Health 2009, 9:186-194.
• [3]Yang WY, Lu JM, Weng JP, Jia WP, Ji LN, Xiao JZ, Shan ZY, Liu J, Tian HM, Ji QH, Zhu DL, Ge JP, Lin LX, Chen L, Guo XH, Zhao ZG, Li Q, Zhou ZG, Shan GL, He J, the China National Diabetes and Metabolic Disorders Study Group: Prevalence of diabetes among men and women in China. New Engl J Med 2010, 362:1090-1101.
• [4]Hunter GR, Chandler-Laney PC, Brock DW, Lara-Castro C, Fernandez JR, Gower BA: Fat distribution, aerobic fitness, blood lipids, and insulin sensitivity in African-American and European-American women. Obesity (Silver Spring) 2010, 18:274-281.
• [5]Leite SA, Anderson RL, Kendall DM, Monk AM, Bergenstal RM: A1C predicts type 2 diabetes and impaired glucose tolerance in a population at risk: the community diabetes prevention project. Diabetol Metab Syndr 2009, 1:5-11.
• [6]Oti SO, Van de Vijver SJ, Agyemang C, Kyobutunqi C: The magnitude of diabetes and its association with obesity in the slum of Nairobi, Kenya: results from a cross-sectional survey. Trop Med Int Health 2013, 18:1520-1530.
• [7]Matsuda M, Shimomura I: Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes Res Clin Pract 2013, 7:e330-e341.
• [8]Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meiqs JB, Cupples LA, D’Aqostino RB Sr, O’Donnell CJ: Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007, 116:39-48.
• [9]DeNino WF, Tchernof A, Dionne IJ, Toth MJ, Ades PA, Sites CK, Poehlman ET: Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care 2001, 24:925-932.
• [10]Bu J, Zhang Y, Chen H, Liang YP, Huang JL: Relationship between visceral fat volume by CT and insulin resistance in type 2 diabetes [Article in Chinese]. Shi Yong Yi Xue Za Zhi 2009, 25:2278-2279.
• [11]Haslam DW, James WP: Obesity. Lancet 2005, 366:1197-1209.
• [12]National Institutes of Health: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res 1998, 6:51S-209S.
• [13]Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, Galluzzo A, AlkaMeSy Study Group: Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 2010, 33:920-922.
• [14]Bozorgmanesh M, Hadaegh F, Azizi F: Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: type 2 diabetes. Lipids Health Dis 2011, 10:88-97.
• [15]Hu XS, Guo ZR, Zhou H, Shi ZM, Wu M, Zhang J, Sun GX, Zhou ZY, Pan XQ, Yao CL: Study on the prevalence of metabolic syndrome among 35–74 year-olds in Jiangsu province [Article in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 2006, 27:751-756.
• [16]Guo ZR, Hu XS, Wu M, Zhou MH, Zhou ZY: A prospective study on the association between dyslipidemia and hypertension [Article in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 2009, 30:554-558.
• [17]Luo WS, Guo ZR, Hu XS, Zhou ZY, Wu M, Zhang LJ, Liu JC: 2 years change of waist circumference and body mass index and associations with type 2 diabetes mellitus in cohort populations. Obes Res Clin Pract 2013, 7:e290-e296.
• [18]Luo WS, Guo ZR, Hu XS, Zhou ZY, Wu M, Zhang LJ, Liu JC: A prospective study on association between 2 years change of waist circumference and incident hypertension in Han Chinese. Int J Cardiol 2013, 167:2781-2785.
• [19]Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition. Circulation 2004, 109:433-438.
• [20]Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
• [21]Cooperative Mata-analysis Group of China Obesity Task Force: Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population [Article in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 2002, 23:5-10.
• [22]Ashwell M, Lejeune S, McPherson K: Ratio of waist circumference to height may be better indicator of need for weight management. BMJ 1996, 312:377.
• [23]National Institutes of Health: Successful diet and exercise therapy is conducted in Vermont for “diabesity”. JAMA 1980, 243:519-520.
• [24]Yang SL, Zhu LY, Hu LY, Wang GY, Ma LC, Li XL, Shan W: The relationship between obesity phenotype and type 2diabetes[Article in Chinese]. Yi Nan Bing Za Zhi 2010, 9:191-193.
• [25]Astrup A, Finer N: Redefining type 2 diabetes: ‘diabesity’ or ‘obesity dependent diabetes mellitus’? Obes Rev 2000, 1:57-59.
• [26]Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S: Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007, 56:1010-1013.
• [27]He HB, Zhao ZG, Pu YF, Chen J, Ni YX, Zhong J, Liu HY, Li YS, Yan ZC, Liu DY, Zhu ZM: Relationship of different types of abdominal obesity to risk of metabolic syndrome [Article in Chinese]. Zhonghua Yi Xue Za Zhi 2008, 88:1251-1254.
• [28]Boden G, Shulman GI: Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 2002, 32(Suppl 3):14-23.
• [29]Liu J, Cao L, Tian LM, Zhong JT, Guo Q: The correlation of plasma visfatin and leptin with insulin resistance in type 2 diabetes [Article in Chinese]. Chin J Diab 2008, 16:521-523.
• [30]Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS: A transgenic model of visceral obesity and the metabolic syndrome. Science 2001, 294:2166-2170.
• [31]Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Charalampidis P, Livadas S, Kollias A, Sabico SL, Chrousos GP: Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances. Eur J Clin Invest 2013, 43:183-189.
• [32]Oh JY, Sung YA, Lee HJ: The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome. Obesity(Silver Spring) 2013, 21:1690-1694.
• [33]Elisha B, Messier V, Karelis A, Coderre L, Bernard S, Prud’homme D, Rabasa-Lhoret R: The visceral adiposity index: Relationship with cardiometabolic risk factors in obese and overweight postmenopausal women – A MONET group study. Appl Physiol Nutr Metab 2013, 38:892-899.
• [34]Ciresi A, Amato MC, Pizzolanti G, Giordano Galluzzo C: Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients. J Clin Endocrinol Metab 2012, 97:2907-2915.
• [35]Lee JW, Brancati FL, Yeh HC: Trends in the prevalence of type 2 diabetes in Asians versus Whites. Diabetes Care 2011, 34:353-357.
• [36]Wang D, Li Y, Lee SG, Wang L, Fan J, Zhang G, Wu J, Ji Y, Li S: Ethnic differences in body composition and obesity related risk factors: study in Chinese and white males living in China. PLoS One 2011, 6:e19835.
• [37]Lear SA, Chen MM, Frohlich JJ, Birmingham CL: The relationship between waist circumference and metabolic risk factors: cohorts of European and Chinese descent. Metabolism 2002, 51:1427-1432.
• [38]Lear SA, Humphries KH, Kohli S, Birmingham CL: The use of BMI and waist circumference as surrogates of body fat differs by ethnicity. Obesity (Silver Spring) 2007, 15:2817-2824.
• [39]Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ, Birmingham CL: Visceral adipose tissue accumulation differs according to ethnic background: results of the multicultural community health assessment trial (M-CHAT). Am J Clin Nutr 2007, 86:353-359.
• [40]Lesser IA, Gasevic D, Lear SA: The effect of body fat distribution on ethnic differences in cardiometabolic risk factors of Chinese and Europeans. Appl Physiol Nutr Metab 2013, 38:701-706.